Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1947 1
1948 3
1949 1
1950 16
1951 17
1952 11
1953 9
1954 16
1955 7
1956 1
1957 8
1958 7
1959 6
1960 5
1961 2
1962 2
1963 5
1964 3
1965 3
1966 7
1967 5
1968 4
1969 4
1970 6
1971 10
1972 14
1973 7
1974 9
1975 8
1976 16
1977 9
1978 10
1979 10
1980 12
1981 8
1982 12
1983 21
1984 8
1985 18
1986 12
1987 19
1988 28
1989 18
1990 15
1991 22
1992 24
1993 27
1994 26
1995 19
1996 40
1997 24
1998 26
1999 32
2000 29
2001 33
2002 31
2003 41
2004 33
2005 41
2006 44
2007 56
2008 42
2009 77
2010 87
2011 95
2012 119
2013 131
2014 91
2015 131
2016 101
2017 110
2018 112
2019 112
2020 109
2021 120
2022 114
2023 122
2024 203
2025 153

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,724 results

Results by year

Filters applied: . Clear all
Page 1
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Fisher MJ, Blakeley JO, Weiss BD, Dombi E, Ahlawat S, Akshintala S, Belzberg AJ, Bornhorst M, Bredella MA, Cai W, Ferner RE, Gross AM, Harris GJ, Listernick R, Ly I, Martin S, Mautner VF, Salamon JM, Salerno KE, Spinner RJ, Staedtke V, Ullrich NJ, Upadhyaya M, Wolters PL, Yohay K, Widemann BC. Fisher MJ, et al. Among authors: gross am. Neuro Oncol. 2022 Nov 2;24(11):1827-1844. doi: 10.1093/neuonc/noac146. Neuro Oncol. 2022. PMID: 35657359 Free PMC article. Review.
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Gross AM, Dombi E, Wolters PL, Baldwin A, Dufek A, Herrera K, Martin S, Derdak J, Heisey KS, Whitcomb PM, Steinberg SM, Venzon DJ, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Smith MA, Widemann BC. Gross AM, et al. Neuro Oncol. 2023 Oct 3;25(10):1883-1894. doi: 10.1093/neuonc/noad086. Neuro Oncol. 2023. PMID: 37115514 Free PMC article. Clinical Trial.
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu TV, Klatt ME, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, Macdougall C, Majumdar A, Mathers AJ, McCreary EK, Miller WR, Monogue ML, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Tamma PD, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu JY, Pogue JM; PRECEDENT Network. Shields RK, et al. Among authors: gross ae. Lancet Infect Dis. 2025 May;25(5):574-584. doi: 10.1016/S1473-3099(24)00648-0. Epub 2024 Dec 16. Lancet Infect Dis. 2025. PMID: 39701120
A slippery slope.
Gross AW, Vickers A, Lee AG, Chen JJ, Bhatti MT. Gross AW, et al. Surv Ophthalmol. 2019 Nov-Dec;64(6):884-890. doi: 10.1016/j.survophthal.2018.10.006. Epub 2018 Oct 30. Surv Ophthalmol. 2019. PMID: 30385270
Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling.
Fiore A, Zeitler L, Russier M, Groß A, Hiller MK, Parker JL, Stier L, Köcher T, Newstead S, Murray PJ. Fiore A, et al. Among authors: gross a. Mol Cell. 2022 Mar 3;82(5):920-932.e7. doi: 10.1016/j.molcel.2022.02.007. Mol Cell. 2022. PMID: 35245456 Free PMC article.
[Hydrocele].
Filmar S, Gross AJ, Hook S, Rosenbaum CM, Netsch C, Becker B. Filmar S, et al. Among authors: gross aj. Urologie. 2024 Jun;63(6):607-617. doi: 10.1007/s00120-024-02367-7. Epub 2024 May 23. Urologie. 2024. PMID: 38780784 Review. German.
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, Dombi E, Fangusaro J, Gelb BD, Hargrave D, Kim A, Klesse LJ, Loh M, Martin S, Moertel C, Packer R, Payne JM, Rauen KA, Rios JJ, Robison N, Schorry EK, Shannon K, Stevenson DA, Stieglitz E, Ullrich NJ, Walsh KS, Weiss BD, Wolters PL, Yohay K, Yohe ME, Widemann BC, Fisher MJ. de Blank PMK, et al. Among authors: gross am. Neuro Oncol. 2022 Nov 2;24(11):1845-1856. doi: 10.1093/neuonc/noac165. Neuro Oncol. 2022. PMID: 35788692 Free PMC article. Review.
The Reply.
Gross A, Sidhu MS, Mathew RO. Gross A, et al. Am J Med. 2024 Nov;137(11):e212. doi: 10.1016/j.amjmed.2024.06.020. Am J Med. 2024. PMID: 39461797 No abstract available.
2,724 results